The U.S. Food and Drug Administration published a final rule
today that sets standards for how information about using medicines
during pregnancy and breastfeeding is presented in the labeling of
prescription drugs and biological products. The new content and
formatting requirements will provide a more consistent way to include
relevant information about the risks and benefits of prescription drugs
and biological products used during pregnancy and breastfeeding.
|